In more than 90% of cases, sarcomatoid mesothelioma is found to have a CDKN2A homozygous deletion or loss of methylthioadenosine phosphorylase gene (MTAP), and in most cases, co-deletion is seen. This evidence concerns the gene CDKN2A and sarcomatoid mesothelioma.